Clinical Trial Update: Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating regional chemotherapy in unresectable or borderline resectable locally advanced pancreatic cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Histologically or Cytologically Confirmed Pancreatic Ca, Unresectable or Borderline Resectable Pancreatic Ca | Phase 1 | Status: COMPLETED | Results posted: 2018-10-01